Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/123444
Title: Sex differences in efficacy and adverse events following bronchoscopic thermal vapour ablation for severe emphysema : results from a multinational real-world registry
Author(s): Trudzinski, FranziskaLook up in the Integrated Authority File of the German National Library
Kontogianni, KonstantinaLook up in the Integrated Authority File of the German National Library
Valipour, ArschangLook up in the Integrated Authority File of the German National Library
Klemm, Theresa AntoniaLook up in the Integrated Authority File of the German National Library
Eisenmann, StephanLook up in the Integrated Authority File of the German National Library
Dittrich, A. SusanneLook up in the Integrated Authority File of the German National Library
Höger, PhilippLook up in the Integrated Authority File of the German National Library
Byczkowski, TeresaLook up in the Integrated Authority File of the German National Library
Feißt, ManuelLook up in the Integrated Authority File of the German National Library
Herth, FelixLook up in the Integrated Authority File of the German National Library
Issue Date: 2026
Type: Article
Language: English
Abstract: Background: Bronchoscopic thermal vapour ablation (BTVA) is a treatment option for selected patients with severe emphysema, inducing lung volume reduction through a localised inflammatory response. This study investigated sex-specific differences in outcomes and safety after BTVA. Methods: Data from the multicentre BTVA post-market registry (December 2018-July 2024) were retrospectively analysed. Sex-specific outcomes at 3, 6 and 12 months were compared, and the effect of sex on residual volume (RV%) was assessed using an adjusted mixed-effects model. Results: A total of 231 patients (105 women) were included. In women, significant improvements were observed in forced expiratory volume in 1 s at 3, 6 and 12 months (+60 mL, +70 mL, +20 mL), RV at 6 and 12 months (-0.38 L and -0.50 L), 6-Minute Walk Distance (6-MWD) at 3 and 6 months (+17.5 m and +23.5 m), and a consistent improvement in St. George’s Respiratory Questionnaire (SGRQ) at 3, 6 and 12 months (-9.3, -6.9, -9.1). In men, significant improvements were noted in RV at 3, 6 and 12 months (-0.32 L, -0.47 L, -0.32 L) and in SGRQ at 3 and 6 months (-4.8 and -3.7), but not at 12 months. An improvement in 6-MWD was not observed in men. Additionally, a significant time-by-sex interaction was observed for RV% (χ²=5.88, p=0.015), indicating distinct RV trajectories between the sexes. Conclusions: The results indicate that women experienced greater improvements in lung function and SGRQ scores after BTVA, which may be explained by differences in perception and reporting of functional benefits, as well as potential biological factors such as a stronger inflammatory response.
Annotations: Zuerst veröffentlicht: 11. März 2026
URI: https://opendata.uni-halle.de//handle/1981185920/125378
http://dx.doi.org/10.25673/123444
Open Access: Open access publication
License: (CC BY-NC 4.0) Creative Commons Attribution NonCommercial 4.0(CC BY-NC 4.0) Creative Commons Attribution NonCommercial 4.0
Journal Title: BMJ Open Respiratory Research
Publisher: BMJ Publishing Group
Publisher Place: London
Volume: 13
Issue: 1
Original Publication: 10.1136/bmjresp-2025-003932
Page Start: 1
Page End: 9
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
e003932.full.pdf373.08 kBAdobe PDFThumbnail
View/Open